Home
Home » companies

Cubist Pharmaceuticals

Investing to Fight Toilet and Elevator Superbugs

Investing to Fight Toilet and Elevator Superbugs
Motley Fool

3 Biotech Stocks with Jaw-Dropping Growth Potential

3 Biotech Stocks with Jaw-Dropping Growth Potential
Motley Fool

Cubist and Durata Heat Up Antibiotic Market

Cubist and Durata Heat Up Antibiotic Market
Motley Fool

Cubist Sivextro sales to benefit from lack of warnings, says JMP Securities

Cubist Sivextro sales to benefit from lack of warnings, says JMP Securities
The Fly on the Wall

FDA approves Cubist drug to treat acute skin infections

FDA approves Cubist drug to treat acute skin infections
Yahoo/Reuters

As Antibiotics Stop Working, Five Biotechs Seek Cures

As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St

Cubist Readies For Takeoff With New Antibiotic Launch

Cubist Readies For Takeoff With New Antibiotic Launch
Investors.com

U.S. FDA advisors set to review opioid constipation drugs

U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters

Superbug Researchers Wait on Future of AstraZeneca Drugs

Superbug Researchers Wait on Future of AstraZeneca Drugs
Bloomberg

Cubist gram-negative antibiotic data supports approval, says JMP Securities

Cubist gram-negative antibiotic data supports approval, says JMP Securities
The Fly on the Wall